314 related articles for article (PubMed ID: 9604801)
1. The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type 1.
Danpure CJ
J Nephrol; 1998; 11 Suppl 1():8-12. PubMed ID: 9604801
[TBL] [Abstract][Full Text] [Related]
2. A unique molecular basis for enzyme mistargeting in primary hyperoxaluria type 1.
Leiper JM; Danpure CJ
Clin Chim Acta; 1997 Oct; 266(1):39-50. PubMed ID: 9435987
[TBL] [Abstract][Full Text] [Related]
3. Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro.
Lumb MJ; Birdsey GM; Danpure CJ
Biochem J; 2003 Aug; 374(Pt 1):79-87. PubMed ID: 12737622
[TBL] [Abstract][Full Text] [Related]
4. Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation.
Danpure CJ; Purdue PE; Fryer P; Griffiths S; Allsop J; Lumb MJ; Guttridge KM; Jennings PR; Scheinman JI; Mauer SM
Am J Hum Genet; 1993 Aug; 53(2):417-32. PubMed ID: 8101040
[TBL] [Abstract][Full Text] [Related]
5. Variable peroxisomal and mitochondrial targeting of alanine: glyoxylate aminotransferase in mammalian evolution and disease.
Danpure CJ
Bioessays; 1997 Apr; 19(4):317-26. PubMed ID: 9136629
[TBL] [Abstract][Full Text] [Related]
6. Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity.
Danpure CJ; Jennings PR; Fryer P; Purdue PE; Allsop J
J Inherit Metab Dis; 1994; 17(4):487-99. PubMed ID: 7967498
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of alanine:glyoxylate aminotransferase 1 dimerization is a prerequisite for its peroxisome-to-mitochondrion mistargeting in primary hyperoxaluria type 1.
Leiper JM; Oatey PB; Danpure CJ
J Cell Biol; 1996 Nov; 135(4):939-51. PubMed ID: 8922378
[TBL] [Abstract][Full Text] [Related]
8. Mammalian alanine/glyoxylate aminotransferase 1 is imported into peroxisomes via the PTS1 translocation pathway. Increased degeneracy and context specificity of the mammalian PTS1 motif and implications for the peroxisome-to-mitochondrion mistargeting of AGT in primary hyperoxaluria type 1.
Motley A; Lumb MJ; Oatey PB; Jennings PR; De Zoysa PA; Wanders RJ; Tabak HF; Danpure CJ
J Cell Biol; 1995 Oct; 131(1):95-109. PubMed ID: 7559790
[TBL] [Abstract][Full Text] [Related]
9. Identification of new mutations in primary hyperoxaluria type 1 (PH1).
von Schnakenburg C; Rumsby G
J Nephrol; 1998; 11 Suppl 1():15-7. PubMed ID: 9604803
[TBL] [Abstract][Full Text] [Related]
10. Three novel deletions in the alanine:glyoxylate aminotransferase gene of three patients with type 1 hyperoxaluria.
Coulter-Mackie MB; Rumsby G; Applegarth DA; Toone JR
Mol Genet Metab; 2001 Nov; 74(3):314-21. PubMed ID: 11708860
[TBL] [Abstract][Full Text] [Related]
11. Genetic heterogeneity in primary hyperoxaluria type 1: impact on diagnosis.
Coulter-Mackie MB; Rumsby G
Mol Genet Metab; 2004; 83(1-2):38-46. PubMed ID: 15464418
[TBL] [Abstract][Full Text] [Related]
12. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways.
Danpure CJ
Biochim Biophys Acta; 2006 Dec; 1763(12):1776-84. PubMed ID: 17027096
[TBL] [Abstract][Full Text] [Related]
13. Effect of N-terminal alpha-helix formation on the dimerization and intracellular targeting of alanine:glyoxylate aminotransferase.
Lumb MJ; Drake AF; Danpure CJ
J Biol Chem; 1999 Jul; 274(29):20587-96. PubMed ID: 10400689
[TBL] [Abstract][Full Text] [Related]
14. Molecular etiology of primary hyperoxaluria type 1: new directions for treatment.
Danpure CJ
Am J Nephrol; 2005; 25(3):303-10. PubMed ID: 15961951
[TBL] [Abstract][Full Text] [Related]
15. Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase.
Santana A; Salido E; Torres A; Shapiro LJ
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7277-82. PubMed ID: 12777626
[TBL] [Abstract][Full Text] [Related]
16. Primary hyperoxaluria type 1 and peroxisome-to-mitochondrion mistargeting of alanine:glyoxylate aminotransferase.
Danpure CJ
Biochimie; 1993; 75(3-4):309-15. PubMed ID: 8507692
[TBL] [Abstract][Full Text] [Related]
17. Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.
Williams EL; Acquaviva C; Amoroso A; Chevalier F; Coulter-Mackie M; Monico CG; Giachino D; Owen T; Robbiano A; Salido E; Waterham H; Rumsby G
Hum Mutat; 2009 Jun; 30(6):910-7. PubMed ID: 19479957
[TBL] [Abstract][Full Text] [Related]
18. Partial deletion of the AGXT gene (EX1_EX7del): A new genotype in hyperoxaluria type 1.
Nogueira PK; Vuong TS; Bouton O; Maillard A; Marchand M; Rolland MO; Cochat P; Bozon D
Hum Mutat; 2000 Apr; 15(4):384-5. PubMed ID: 10737993
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor.
Coulter-Mackie MB; Lian Q; Wong SG
Protein Expr Purif; 2005 May; 41(1):18-26. PubMed ID: 15802217
[TBL] [Abstract][Full Text] [Related]
20. Preliminary evidence for ethnic differences in primary hyperoxaluria type 1 genotype.
Coulter-Mackie MB
Am J Nephrol; 2005; 25(3):264-8. PubMed ID: 15961945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
